SpaceX IPO launches today. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSpirax-Sarco Regulatory News (SPX)

Share Price Information for Spirax-Sarco (SPX)

Share Price is delayed by 15 minutes
Get Live Data
6,760.00    65.00 (0.97%)
Bid:
6,755.00
Ask:
6,760.00
Spread: 5.00 (0.074%)
Market Cap: £4.99b
SPX Live PriceLast checked at - London Stock Exchange

Intraday Spirax-Sarco Share Chart

Future Board Change

30 Jan 2024 11:15

RNS Number : 2847B
Spirax-Sarco Engineering PLC
30 January 2024
 

 

 

 

30th January 2024

 

FUTURE BOARD CHANGE

 

 

In accordance with the Listing Rule requirement to give notice of new directorships held by current directors (LR 9.6.14 (2)), Spirax-Sarco Engineering plc announces that Jamie Pike, Chair of the Board and Non-Executive Director, will be appointed as Chair and Non-Executive Director of IMI plc with effect from 1st January 2025.

 

The Board of Spirax-Sarco Engineering plc previously announced that Jamie would step down as Chair and Non-Executive Director during 2024, following the expiry of his nine years as a Director. A process to appoint his successor is well advanced.

 

The Board is satisfied that Jamie's appointment with IMI plc complies with the UK Corporate Governance Code 2018 and proxy advisor guidelines.

 

 

Enquiries:

 

Andy Robson, General Counsel

Tel: 01242 535276

 

 

About Spirax?Sarco Engineering plc

Spirax?Sarco Engineering plc is a leading global thermal energy management and fluid technology solutions Group. It comprises three world?leading Businesses: Steam Specialties, for the control and management of steam; Electric Thermal Solutions, for advanced electrical process heating and temperature management solutions; and Watson-Marlow, for peristaltic pumping and associated fluid path technologies. The Steam Specialties and Electric Thermal Solutions Businesses provide a broad range of fluid control and process heating products, engineered packages, site services and systems expertise for a diverse range of industrial and institutional customers. Both businesses help their customers improve process efficiencies, meet environmental sustainability targets, improve product quality and enhance the safety of their operations. Watson?Marlow provides solutions for a wide variety of demanding fluid path applications with highly accurate, controllable and virtually maintenance-free pumps and associated technologies.

 

The Group is headquartered in Cheltenham (UK), has 40 strategically located manufacturing plants around the world and employs more than 10,000 people, including more than 2,100 direct sales and service engineers. The Company's shares have been listed on the London Stock Exchange since 1959 (symbol: SPX) and it is a constituent of the FTSE 100 and the FTSE4Good Indexes.

 

 

Further information can be found at spiraxsarcoengineering.com

 

RNS filter: Inside Information prior to release

LEI 213800WFVZQMHOZP2W17

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAPPUAAGUPCGRB
Date   Source Headline
6th Jun 20112:49 pmRNSDirector/PDMR Shareholding
6th Jun 20112:46 pmRNSTotal Voting Rights
27th May 20117:00 amRNSDirectorate Change
12th May 20115:23 pmRNSAGM Statement
10th May 20111:00 pmRNSInterim Management Statement
9th May 20111:38 pmRNSHolding(s) in Company
6th May 20114:25 pmRNSTotal Voting Rights
27th Apr 20119:16 amRNSDirector Declaration
6th Apr 20113:34 pmRNSHolding(s) in Company
1st Apr 20114:50 pmRNSDirector/PDMR Shareholding
1st Apr 20114:48 pmRNSTotal Voting Rights
29th Mar 20115:22 pmRNSDirector/PDMR Shareholding
23rd Mar 20114:48 pmRNSAnnual Financial Report
21st Mar 20113:44 pmRNSDirector/PDMR Shareholding
18th Mar 20114:34 pmRNSDirector/PDMR Shareholding
16th Mar 20114:32 pmRNSDirector/PDMR Shareholding
9th Mar 201110:48 amRNSDirector/PDMR Shareholding
8th Mar 20117:00 amRNS2010 Preliminary Results
1st Mar 20119:28 amRNSTotal Voting Rights
3rd Feb 20115:12 pmRNSHolding(s) in Company
1st Feb 201110:52 amRNSTotal Voting Rights
13th Jan 20114:04 pmRNSNotice of Results
5th Jan 201110:06 amRNSTotal Voting Rights
1st Dec 20104:58 pmRNSTotal Voting Rights
15th Nov 20103:24 pmRNSDirector/PDMR Shareholding
8th Nov 20107:00 amRNSInterim Management Statement
1st Nov 20102:08 pmRNSTotal Voting Rights
28th Oct 201010:53 amRNSDirector Declaration
26th Oct 20108:29 amRNSHolding(s) in Company
26th Oct 20108:29 amRNSHolding(s) in Company
19th Oct 20104:20 pmRNSHolding(s) in Company
12th Oct 201011:06 amRNSAmendment - Director/PDMR Shareholding
11th Oct 20104:43 pmRNSDirector/PDMR Shareholding
1st Oct 20101:13 pmRNSTotal Voting Rights
6th Sep 20104:06 pmRNSDirector/PDMR Shareholding
6th Sep 201010:55 amRNSHolding(s) in Company
2nd Sep 201010:39 amRNSTotal Voting Rights
26th Aug 201011:18 amRNSDirector/PDMR Shareholding
24th Aug 20107:00 amRNS2010 Half Year Results
2nd Aug 20104:26 pmRNSTotal Voting Rights
9th Jul 20109:14 amRNSHolding(s) in Company
7th Jul 201011:59 amRNSAcquisition - Replacement Announcement
7th Jul 201011:32 amRNSAcquisition
7th Jul 20109:55 amRNSHolding(s) in Company
6th Jul 20103:35 pmRNSHolding(s) in Company
6th Jul 20108:44 amRNSHolding(s) in Company
6th Jul 20107:00 amRNSTrading update
1st Jul 201011:15 amRNSTotal Voting Rights
17th Jun 201010:01 amRNSDirector Declaration
15th Jun 20102:48 pmRNSNotice of Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.